Segall Bryant & Hamill’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,174
Closed -$311K 524
2023
Q2
$311K Buy
2,174
+118
+6% +$17.4K ﹤0.01% 637
2023
Q1
$285K Hold
2,056
﹤0.01% 649
2022
Q4
$278K Hold
2,056
﹤0.01% 657
2022
Q3
$226K Buy
2,056
+44
+2% +$5.58K ﹤0.01% 685
2022
Q2
$265K Sell
2,012
-150
-7% -$19.7K ﹤0.01% 678
2022
Q1
$287K Buy
+2,162
New +$259K ﹤0.01% 684
2021
Q4
Sell
-1,954
Closed -$234K 603
2021
Q3
$234K Buy
1,954
+17
+0.9% +$1.98K ﹤0.01% 742
2021
Q2
$232K Sell
1,937
-11,590
-86% -$1.27M ﹤0.01% 723
2021
Q1
$1.34M Buy
+13,527
New +$1.36M 0.01% 517

Other funds holding AZN